These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 9844479

  • 1. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M.
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract] [Full Text] [Related]

  • 2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 3. [Pseudomonas aeruginosa. A pathogenic microbe of current importance].
    Bergan T.
    Tidsskr Nor Laegeforen; 1969 Jun 15; 89(12):1014-6. PubMed ID: 4979183
    [No Abstract] [Full Text] [Related]

  • 4. [Bacteremia, endocarditis and meningitis caused by Pseudomonas aeruginosa].
    Cisneros Herreros JM, Cañas García-Otero E, Caballero Granado J, Becerril Carral B.
    Rev Clin Esp; 1998 Sep 15; 198 Suppl 2():25-9. PubMed ID: 9844475
    [No Abstract] [Full Text] [Related]

  • 5. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
    Výmola F, Jedlicková Z.
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jul 15; 21(4):176-81. PubMed ID: 4262242
    [No Abstract] [Full Text] [Related]

  • 6. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C, Tassara A.
    G Mal Infett Parassit; 1971 Nov 15; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract] [Full Text] [Related]

  • 7. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
    van Delden C.
    Int J Antimicrob Agents; 2007 Nov 15; 30 Suppl 1():S71-5. PubMed ID: 17698326
    [Abstract] [Full Text] [Related]

  • 8. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
    Tam VH, Chang KT, Schilling AN, LaRocco MT, Genty LO, Garey KW.
    Diagn Microbiol Infect Dis; 2009 Mar 15; 63(3):279-85. PubMed ID: 19135330
    [Abstract] [Full Text] [Related]

  • 9. The changing character of infective endocarditis.
    Quinn EL, Burch KH, Cox F, Fisher E, Madhavan T.
    Am Fam Physician; 1975 Mar 15; 11(3):117-24. PubMed ID: 803764
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effective agents against Pseudomonas pyocyanea (proceedings)].
    Meyer-Rohn J.
    Z Hautkr; 1976 Mar 15; 51 Suppl 2():106-8. PubMed ID: 827860
    [No Abstract] [Full Text] [Related]

  • 12. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y, Yanagihara K, Nakamura S, Yamamoto K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yamada Y, Kohno S, Kamihira S.
    J Antimicrob Chemother; 2008 Dec 15; 62(6):1326-31. PubMed ID: 18835805
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ.
    Br J Hosp Med; 1984 Feb 15; 31(2):136-40. PubMed ID: 6421353
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
    Chernomordik AB, Panchenko MK, Bulycheva NP.
    Klin Med (Mosk); 1982 Jun 15; 60(6):17-20. PubMed ID: 6811797
    [No Abstract] [Full Text] [Related]

  • 19. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB, Noomen S, Khélifa AB, Sahnoun O, Elargoubi A, Mastouri M.
    Med Mal Infect; 2008 Oct 15; 38(10):554-6. PubMed ID: 18814981
    [Abstract] [Full Text] [Related]

  • 20. [Recommendations for the treatment of nosocomial infections caused by Gram-positive microorganisms].
    Azanza JR, Barberán J, García-Rodríguez JA, Llinares P, Mensa J, Picazo J, Prieto J, Torre Cisneros J.
    Rev Esp Quimioter; 2004 Sep 15; 17(3):271-88. PubMed ID: 15619658
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.